Kaitlyn D’Onofrio

DocwireNews

Studies have found that health promotion is beneficial for patients with multiple sclerosis (MS), but many of these studies have focused on patients with relapsing-remitting MS, with less available data for those with progressive MS. A study compared health promotion and quality of life (QOL) between patients with progressive versus non-progressive MS.Data from years 21 and 22 of an ongoing longitudinal study of patients with MS were evaluated; patients were compared based on demographic, psychosocial, and health promotion factors, as well as the 36-Item Short Form Health Survey (SF-36) QOL subscales. The researchers entered barriers, symptom clusters, social supports, and health promotion activities into hierarchical multivariate regressions to forecast SF-36 subscale scores between patients with progressive versus non-progressive MS. Analyses controlled for years of education and MS incapacity.Seventy-two patients with progressive MS and 117 patients with non-progressive MS were analyzed. Health promotion and SF-36 physical role limitations and social functioning were significantly poorer in the progressive MS group. In both cohorts, a significant association was observed between symptoms and all three SF-36 subscales. MS course was significantly associated with variances in the hierarchical models: in progressive MS, adjusted R2 scores ranged from 0.17 to 0.30 compared with 0.35 to 0.45 in non-progressive MS.In their conclusion, the researchers recommended, &ldquo;The scope of symptom management for people with progressive MS should be broader and not limited only to symptoms typically associated with MS. Non-pharmaceutical therapies targeting symptoms such as fatigue could be considered and are being addressed in several ongoing studies of MS.&rdquo;

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Latest News

Differences in Health Promotion, QOL in Progressive Versus Non-Progressive MS

Multiple Sclerosis

Studies have found that health promotion is beneficial for patients with multiple sclerosis (MS), but many of these studies have focused on patients with relapsing-remitting ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe